---
schema_version: "secwatch.filing_event.v1"
accession: "0000805928-23-000017"
form_type: "8-K"
ticker: "AXGN"
cik: "0000805928"
company_name: "Axogen, Inc."
filed_at: "2023-03-14T23:59:59+00:00"
generated_at: "2026-06-18T04:04:42.088062+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Axogen reports Q4 revenue $36.2M (+17% YoY); guides FY2023 revenue $154M-$159M

## Summary
- Q4 revenue $36.2M, up 17% YoY; gross margin 83.0%; net loss $5.4M ($0.13/sh).
- Full-year 2022 revenue $138.6M, up 12% YoY; adjusted net loss $12.6M.
- Cash and investments $55.0M at Dec 31, 2022; notes $8M at SVB now accessible.
- 2023 revenue guidance $154M-$159M; gross margin expected ~80% by Q4 2023.
- Active Accounts 968; Core Accounts 332; 115 direct sales representatives.

## SEC filing metadata
- accession: 0000805928-23-000017
- form_type: 8-K
- ticker: AXGN
- cik: 0000805928
- company_name: Axogen, Inc.
- filed_at: 2023-03-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/axgn-20230314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000805928-23-000017
- JSON: https://secwatch.observer/filing/0000805928-23-000017.json
- Plain text: https://secwatch.observer/filing/0000805928-23-000017.txt

## Key facts
- Earnings Releases
  Axogen, Inc. reported fourth quarter ended December 31, 2022 results: revenue $36.2 million, net income $5.4 million, EPS $0.13 per share.
  - Period: fourth quarter ended December 31, 2022
  - Revenue: $36.2 million
  - Net income: $5.4 million
  - EPS: $0.13 per share
  - Result: reported results
  source text: Fourth Quarter 2022 Financial Results and Business Highlights • Fourth quarter revenue was $36.2 million, a 17% increase compared to fourth quarter of 2021.* • Gross margin was 83.0% for the fourth quarter compared to 82.8% in the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm
- Earnings Releases
  Axogen, Inc. reported full year 2023 results: revenue $154 million to $159 million. Guidance initiated.
  - Period: full year 2023
  - Revenue: $154 million to $159 million
  - Guidance: initiated
  - Result: guidance update
  source text: Management expects full-year 2023 revenue to be in the range of $154 million to $159 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm
- Earnings Releases
  Axogen, Inc. reported full year ended December 31, 2022 results: revenue $138.6 million.
  - Period: full year ended December 31, 2022
  - Revenue: $138.6 million
  - Result: reported results
  source text: ved hospital operating environment and commercial execution, backed by our high-quality portfolio of clinical data provides a solid foundation for long term, sustainable growth.” Full-Year Financial Results and Business Highlights • Full-year 2022 revenue was $138.6 million, a 12% increase compared to 2021 revenue of $127.4 million.* • Gross margin was 82.6% for the full year, compared to 82.0% in 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/805928/000080592823000017/0000805928-23-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.